CSTL Outperforms MIA
CSTL's DecisionDx-Melanoma's i31-SLNB outperforms MIA Nomogram in identifying patients who may safely forgo sentinel lymph node biopsy
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
CSTL's DecisionDx-Melanoma's i31-SLNB outperforms MIA Nomogram in identifying patients who may safely forgo sentinel lymph node biopsy